Nasdaq
華爾街日報Getting In Cheap On Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Might Be Difficult
When close to half the companies in Saudi Arabia have price-to-earnings ratios (or "P/E's") below 17x, you may consider Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) as a stock to avoid entirely with its 36.6x P/E ratio. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/E.
There hasn't been much to differentiate Dr. Sulaiman Al Habib Medical Services Group's and the market's earnings growth lately. One possibility is that the P/E is high because investors think this modest earnings performance will accelerate. If not, then existing shareholders may be a little nervous about the viability of the share price.
Check out our latest analysis for Dr. Sulaiman Al Habib Medical Services Group
Is There Enough Growth For Dr. Sulaiman Al Habib Medical Services Group?
The only time you'd be truly comfortable seeing a P/E as steep as Dr. Sulaiman Al Habib Medical Services Group's is when the company's growth is on track to outshine the market decidedly.
Taking a look back first, we see that the company managed to grow earnings per share by a handy 6.2% last year. The latest three year period has also seen an excellent 48% overall rise in EPS, aided somewhat by its short-term performance. So we can start by confirming that the company has done a great job of growing earnings over that time.
Turning to the outlook, the next three years should generate growth of 18% per annum as estimated by the nine analysts watching the company. That's shaping up to be materially higher than the 12% each year growth forecast for the broader market.
In light of this, it's understandable that Dr. Sulaiman Al Habib Medical Services Group's P/E sits above the majority of other companies. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.
The Final Word
Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.
We've established that Dr. Sulaiman Al Habib Medical Services Group maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. Right now shareholders are comfortable with the P/E as they are quite confident future earnings aren't under threat. Unless these conditions change, they will continue to provide strong support to the share price.
Don't forget that there may be other risks. For instance, we've identified 1 warning sign for Dr. Sulaiman Al Habib Medical Services Group that you should be aware of.
If you're unsure about the strength of Dr. Sulaiman Al Habib Medical Services Group's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.